These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35453625)

  • 61. Impacts of PBDE-47 exposure before, during and after pregnancy on the maternal gut microbiome and its association with host metabolism.
    Gao H; Wan X; Xiao B; Yang K; Wang Y; Zhang C; Li P; Liu L; Xia T; Wang A; Zhang S
    Ecotoxicol Environ Saf; 2021 Oct; 222():112530. PubMed ID: 34280840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Developmental Programming of Adult Disease: Reprogramming by Melatonin?
    Tain YL; Huang LT; Hsu CN
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212315
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.
    Pekmez CT; Dragsted LO; Brahe LK
    Clin Nutr; 2019 Apr; 38(2):615-630. PubMed ID: 29496274
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microbiota and Food Allergy.
    Shu SA; Yuen AWT; Woo E; Chu KH; Kwan HS; Yang GX; Yang Y; Leung PSC
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):83-97. PubMed ID: 30564985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diabetes and the Gut Microbiome.
    Lau WL; Tran T; Rhee CM; Kalantar-Zadeh K; Vaziri ND
    Semin Nephrol; 2021 Mar; 41(2):104-113. PubMed ID: 34140089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
    Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
    Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.
    Marques FZ; Nelson E; Chu PY; Horlock D; Fiedler A; Ziemann M; Tan JK; Kuruppu S; Rajapakse NW; El-Osta A; Mackay CR; Kaye DM
    Circulation; 2017 Mar; 135(10):964-977. PubMed ID: 27927713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Developmental Origins of Kidney Disease: Why Oxidative Stress Matters?
    Hsu CN; Tain YL
    Antioxidants (Basel); 2020 Dec; 10(1):. PubMed ID: 33396856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of early life gut colonization on metabolic and obesogenic outcomes: what have animal models shown us?
    Wallace JG; Gohir W; Sloboda DM
    J Dev Orig Health Dis; 2016 Feb; 7(1):15-24. PubMed ID: 26399435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension.
    Marques FZ; Jama HA; Tsyganov K; Gill PA; Rhys-Jones D; Muralitharan RR; Muir J; Holmes A; Mackay CR
    Hypertension; 2019 Dec; 74(6):1279-1293. PubMed ID: 31679421
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diet-induced dysbiosis of the maternal gut microbiome in early life programming of neurodevelopmental disorders.
    Di Gesù CM; Matz LM; Buffington SA
    Neurosci Res; 2021 Jul; 168():3-19. PubMed ID: 33992660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The postnatal window is critical for the development of sex-specific metabolic and gut microbiota outcomes in offspring.
    Daoust L; Choi BS; Lacroix S; Rodrigues Vilela V; Varin TV; Dudonné S; Pilon G; Roy D; Levy E; Desjardins Y; Chassaing B; Marette A
    Gut Microbes; 2021; 13(1):2004070. PubMed ID: 34812123
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early Origins of Hypertension: Should Prevention Start Before Birth Using Natural Antioxidants?
    Hsu CN; Tain YL
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33113999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bovine Animal Model for Studying the Maternal Microbiome,
    Amat S; Dahlen CR; Swanson KC; Ward AK; Reynolds LP; Caton JS
    Front Microbiol; 2022; 13():854453. PubMed ID: 35283808
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins.
    Hsu CN; Tain YL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751631
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biochemical basis for pharmacological intervention as a reprogramming strategy against hypertension and kidney disease of developmental origin.
    Tain YL; Chan SHH; Chan JYH
    Biochem Pharmacol; 2018 Jul; 153():82-90. PubMed ID: 29309755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.